Cargando…
The GPIIIA PlA2 polymorphism is associated with an increased risk of cardiovascular adverse events
BACKGROUND: The clinical impact of PlA2 polymorphism has been investigated in several diseases, but the definition of its specific role on thrombotic cardiovascular complications has been challenging. We aimed to explore the effect of PlA2 polymorphism on outcome in patients with atherosclerosis. ME...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2954874/ https://www.ncbi.nlm.nih.gov/pubmed/20846430 http://dx.doi.org/10.1186/1471-2261-10-41 |